MedTrace Logo

Pancreatic Cancer Dietary Assessment Study

NCT03616431 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2023-08-25

No results posted yet for this study

Summary

This is a prospective observational study which aims to evaluate;

The prevalence of pancreatic insufficiency in patients with pancreatic malignancies (adenocarcinoma and neuroendocrine tumours).

The most appropriate diagnostic strategy. The impact that an adequate diagnosis and treatment may have on patients' outcome.

Conditions

  • Pancreatic Neoplasm
  • Pancreas Adenocarcinoma
  • Well-Differentiated Neuroendocrine Carcinoma
  • Malignant Neoplasm of Pancreas

Interventions

DIAGNOSTIC_TEST

Pancreo-KIT breath test

Pancreo-Kit (Isomed Pharma, Madrid, Spain) is a breath test devised to measure Pancreatic Enzyme Insufficiency. It is a non-invasive method to obtain information about the digestion of consumed lipids; this in turn is informative about the exocrine enzyme activity of the pancreas (specifically pancreatic lipase). This kit is manufactured to EC directive 98/79/EEC and carries the CE mark. The test is based on measurement of 13C which is a stable naturally occurring environmental isotope of carbon with a nucleus containing 6 protons and 7 neutrons (note, it is not radioactive).

Sponsors & Collaborators

  • Pancreatic Cancer UK

    collaborator OTHER

  • The Christie NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Juan W Valle, Professor · The Christie NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-03
Primary Completion
2020-10-30
Completion
2021-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03616431 on ClinicalTrials.gov